Based on this data, it is likely that this platform will also function well like a carrier for additional small nonimmunogenic molecules
Based on this data, it is likely that this platform will also function well like a carrier for additional small nonimmunogenic molecules. Because a large percentage of the population has anti-Ad immunity, challenging remained to leverage the full potential of Ad-based vaccines in the context of Ad immunity. mind of APD668 APD668 anti-Ad immune mice.…